Variant report
Variant | esv3348818 |
---|---|
Chromosome Location | chr11:105670442-105673640 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188925762 | chr11:105670550-105670551 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs76860658 | chr11:105670554-105670555 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs577470939 | chr11:105670595-105670596 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560628122 | chr11:105670596-105670597 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191798105 | chr11:105670640-105670641 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542978784 | chr11:105670678-105670679 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184690710 | chr11:105670692-105670693 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7129285 | chr11:105670723-105670724 | Enhancers Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs540938978 | chr11:105670739-105670740 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555993153 | chr11:105670741-105670742 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs373343212 | chr11:105670752-105670753 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs200214137 | chr11:105670811-105670812 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs376921549 | chr11:105670814-105670815 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs541841561 | chr11:105670819-105670820 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs532257217 | chr11:105670835-105670836 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552442146 | chr11:105670858-105670859 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs376994691 | chr11:105670867-105670868 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs530563945 | chr11:105670893-105670894 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs545444612 | chr11:105670903-105670904 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs180962303 | chr11:105670908-105670909 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs370352988 | chr11:105670912-105670913 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs35158473 | chr11:105670931-105670932 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs373707580 | chr11:105670958-105670959 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs528235511 | chr11:105670966-105670967 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544811982 | chr11:105670996-105670997 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs568372174 | chr11:105671004-105671005 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs185905326 | chr11:105671008-105671009 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs35326166 | chr11:105671121-105671122 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189514214 | chr11:105671127-105671128 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs181905886 | chr11:105671161-105671162 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs143415502 | chr11:105671163-105671164 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs368138008 | chr11:105671174-105671175 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs72985126 | chr11:105671190-105671191 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs186265652 | chr11:105671194-105671195 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558245985 | chr11:105671211-105671212 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs567086998 | chr11:105671290-105671291 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs534378481 | chr11:105671296-105671297 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs370386283 | chr11:105671423-105671424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs555664372 | chr11:105671424-105671425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574314802 | chr11:105671433-105671434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs190538585 | chr11:105671441-105671442 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs139361043 | chr11:105671443-105671444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs181527442 | chr11:105671457-105671458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs368893822 | chr11:105671489-105671490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs201540158 | chr11:105671502-105671503 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs141692488 | chr11:105671505-105671506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs35248646 | chr11:105671506-105671507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs5794425 | chr11:105671510-105671511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs567732005 | chr11:105671543-105671544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs374330011 | chr11:105671586-105671587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Melanoma | 17363583 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Obesity | 19966786 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17142309 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:105658000-105689400 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
2 | chr11:105658200-105693200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
3 | chr11:105659800-105672600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr11:105669800-105671000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr11:105670000-105670800 | Enhancers | Brain Hippocampus Middle | brain |
6 | chr11:105670000-105671000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr11:105670400-105671000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
8 | chr11:105670400-105671400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr11:105670600-105671000 | Active TSS | Brain Anterior Caudate | brain |
10 | chr11:105670600-105671200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr11:105670600-105671200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr11:105670600-105671200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
13 | chr11:105670600-105671200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
14 | chr11:105670600-105671200 | Enhancers | HUVEC | blood vessel |
15 | chr11:105672600-105672800 | ZNF genes & repeats | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
16 | chr11:105672600-105672800 | Enhancers | Brain Anterior Caudate | brain |
17 | chr11:105672600-105673000 | Enhancers | Brain Cingulate Gyrus | brain |